Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongming Growth (Beijing) Biotechnology Co., Ltd. is a specialized life sciences company based in Beijing, China, focused on the development and supply of high-quality research reagents and laboratory instruments. Founded in 2010, the company provides a comprehensive range of products for molecular biology, cell biology, and immunology, including nucleic acid extraction kits, PCR reagents, and protein purification systems. Dongming Growth serves a diverse clientele across academic research, clinical diagnostics, and pharmaceutical R&D, positioning itself as a key provider of essential tools for genomic and proteomic studies. In addition to its product catalog, the company offers custom services for molecular biology and protein expression to support specific research needs. With a commitment to innovation and quality, Dongming Growth has established a strong presence in the Chinese biotech ecosystem as a reliable partner for life science researchers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dongming Growth.